FTC sues main pharmacy advantage managers over insulin costs The company introduced motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the checklist price of lifestyle-preserving insulin medicine. The offer should be concluded by Sept. 30 or purchasers can terminate https://buschlightpeachnutritionf95284.blogdemls.com/30451713/facts-about-healthcare-news-revealed